Santarus Inc. buy melinda
Start price
11.01.12
/
50%
€3.42
Target price
19.01.12
€4.50
Performance (%)
-9.57%
End price
19.01.12
€3.09
Summary
This prediction ended on 19.01.12 with a price of €3.09. With a performance of -9.57%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Santarus Inc. | - | - | - | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
Comments by melinda for this prediction
In the thread Santarus Inc. diskutieren
Typ 2 Diabetes
Santarus Inc. ist ein biopharmazeutisches Unternehmen entwickelt und vermarktet Produkte für Miss Blutzuckerkontrolle bei Typ 2 Diabetikern
(Vom Mitglied beendet)